drugset / Trial / NCT06899724

Methoxyflurane for Analgesia During Hysteroscopy

NCT06899724

RandomizedParallel-groupTriple-blindTreatment

Summary

This study is to assess the non-inferiority of using inhaled methoxyflurane (MOF) versus intravenous conscious sedation with fentanyl and midazolam on women's perception of pain, during hysteroscopy and/or polypectomy in an outpatient setting. The researchers will determine whether the participants receiving the inhaled MOF (experimental group) achieve similar clinical effects in reduction of pain and ability to complete the procedure. Women's perception of pain will be recorded on a scale from 0 to 10 using the numeric rating scale (NRS).

Timeline

Start
2025-06-01
Primary completion
2025-12-31
Completion
2026-01-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 1 ug/kg Intravenous
Comparator Methoxyflurane Small molecule 3 ml Inhaled
Comparator Midazolam Small molecule 1 mg Intravenous
Comparator Midazolam Small molecule 3 mg Intravenous

Indications

No indication recorded.